We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Globus Medical Inc | NYSE:GMED | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 50.43 | 0 | 09:00:00 |
1. Name and Address of Reporting Person * Demski David M | 2. Issuer Name and Ticker or Trading Symbol GLOBUS MEDICAL INC [ GMED ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President, CEO |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Class A Common Stock | 4/23/2021 | M | 21875 | A | $43.77 | 21875 | D | |||
Class A Common Stock | 4/23/2021 | M | 21875 | A | $43.58 | 43750 | D | |||
Class A Common Stock | 4/23/2021 | M | 22821 | A | $29.31 | 66571 | D | |||
Class A Common Stock | 4/23/2021 | M | 54688 | A | $53.27 | 121259 | D | |||
Class A Common Stock | 4/23/2021 | S(1) | 121259 | D | $71.59 (2) | 0 | D | |||
Class A Common Stock | 4/26/2021 | M | 78334 | A | $26.27 | 78334 | D | |||
Class A Common Stock | 4/26/2021 | M | 65929 | A | $29.31 | 144263 | D | |||
Class A Common Stock | 4/26/2021 | S(1) | 144263 | D | $71.50 (3) | 0 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy Class A Common Stock) | $43.77 | 4/23/2021 | M | 21875 | (4) | 1/22/2028 | Class A Common Stock | 21875 | $0.00 | 28125 | D | ||||
Stock Option (Right to Buy Class A Common Stock) | $43.58 | 4/23/2021 | M | 21875 | (5) | 1/22/2029 | Class A Common Stock | 21875 | $0.00 | 65625 | D | ||||
Stock Option (Right to Buy Class A Common Stock) | $29.31 | 4/23/2021 | M | 22821 | (6) | 8/28/2027 | Class A Common Stock | 22821 | $0.00 | 97179 | D | ||||
Stock Option (Right to Buy Class A Common Stock) | $53.27 | 4/23/2021 | M | 54688 | (7) | 1/22/2030 | Class A Common Stock | 54688 | $0.00 | 120312 | D | ||||
Stock Option (Right to Buy Class A Common Stock) | $26.27 | 4/26/2021 | M | 78334 | (8) | 1/30/2027 | Class A Common Stock | 78334 | $0.00 | 0 | D | ||||
Stock Option (Right to Buy Class A Common Stock) | $29.31 | 4/26/2021 | M | 65929 | (6) | 8/28/2027 | Class A Common Stock | 65929 | $0.00 | 31250 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Demski David M VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON, PA 19403 | X | President, CEO |
Signatures | ||
/s/ Kelly G. Huller, Attorney-in-Fact | 4/27/2021 | |
**Signature of Reporting Person | Date |
1 Year Globus Medical Chart |
1 Month Globus Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions